Dimensional Fund Advisors LP Purchases 769,569 Shares of Tilray Inc (NASDAQ:TLRY)

Dimensional Fund Advisors LP increased its position in Tilray Inc (NASDAQ:TLRY - Free Report) by 54.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,172,935 shares of the company's stock after purchasing an additional 769,569 shares during the quarter. Dimensional Fund Advisors LP owned approximately 0.23% of Tilray worth $2,890,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the company. Newman Dignan & Sheerar Inc. grew its stake in Tilray by 61.9% in the 4th quarter. Newman Dignan & Sheerar Inc. now owns 26,150 shares of the company's stock valued at $35,000 after buying an additional 10,000 shares during the last quarter. NewEdge Advisors LLC grew its stake in Tilray by 92.1% in the 4th quarter. NewEdge Advisors LLC now owns 27,406 shares of the company's stock valued at $36,000 after buying an additional 13,136 shares during the last quarter. KBC Group NV grew its stake in Tilray by 75.9% in the 4th quarter. KBC Group NV now owns 38,332 shares of the company's stock valued at $51,000 after buying an additional 16,539 shares during the last quarter. Jones Financial Companies Lllp grew its stake in Tilray by 125.7% in the 4th quarter. Jones Financial Companies Lllp now owns 31,725 shares of the company's stock valued at $42,000 after buying an additional 17,670 shares during the last quarter. Finally, Pallas Capital Advisors LLC grew its stake in Tilray by 59.4% in the 4th quarter. Pallas Capital Advisors LLC now owns 50,438 shares of the company's stock valued at $67,000 after buying an additional 18,792 shares during the last quarter. 9.35% of the stock is owned by institutional investors.

Tilray Stock Performance

Shares of NASDAQ:TLRY traded down $0.01 on Wednesday, reaching $0.44. 12,563,442 shares of the company's stock were exchanged, compared to its average volume of 28,384,494. The company has a fifty day moving average of $0.54 and a 200-day moving average of $0.98. Tilray Inc has a twelve month low of $0.41 and a twelve month high of $2.23. The company has a market capitalization of $444.27 million, a price-to-earnings ratio of -1.47 and a beta of 1.95. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10.

Tilray (NASDAQ:TLRY - Get Free Report) last announced its earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.06). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The business had revenue of $185.78 million for the quarter, compared to analyst estimates of $213.38 million. On average, research analysts predict that Tilray Inc will post -0.2 EPS for the current fiscal year.

Analysts Set New Price Targets

TLRY has been the topic of a number of research reports. Piper Sandler decreased their price target on shares of Tilray from $2.00 to $1.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 9th. Roth Capital restated a "neutral" rating on shares of Tilray in a research report on Monday, April 14th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.